Affini-T Therapeutics

About:

Affini-T Therapeutics is a biotechnology company developing T-cell therapies for patients suffering from cancer.

Website: https://www.affinittx.com

Twitter/X: affinit_tx

Top Investors: Fred Hutchinson, Alexandria Venture Investments, Catalio Capital Management, Leaps by Bayer, Vida Ventures

Description:

Affini-T Therapeutics is a biotechnology company developing T-cell therapies for patients suffering from cancer. Affini-T uses a validated platform to select high-affinity T cell receptors specific to oncogenic mutations to pioneer cutting-edge solid tumor therapies. Affini-T leverages gene editing and synthetic biology to engineer novel T-cell therapies designed to eradicate tumors.